Dow Down0.12% Nasdaq Down0.04%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NMS
2.70 Down 0.04(1.28%) 9:41AM EDT - Nasdaq Real Time Price
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Net Income (18,135) (14,621) 4,901   (15,164)
Operating Activities, Cash Flows Provided By or Used In
Depreciation153  152  159  155  
Adjustments To Net Income1,703  2,300  4,471  1,795  
Changes In Accounts Receivables1,252  (3,199)1,298  3,896  
Changes In Liabilities1,920  819  8,596  4,257  
Changes In Inventories(1,612)1,308  (98)(527)
Changes In Other Operating Activities(109)581  (1,229)1,862  
Total Cash Flow From Operating Activities (14,828) (12,660) 18,098   (3,726)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,046)(142)(369)(565)
Investments1,049  (17,946)6,373  (896)
Other Cash flows from Investing Activities10  (53)1,068  (2,487)
Total Cash Flows From Investing Activities (2,987) (18,141) 7,072   (3,948)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock87  647  3,244  1,501  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 87   647   3,244   1,501  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (17,728) (30,154) 28,414   (6,173)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.